Boundless Bio Inc 's

• BOLD's Stock Performance relative to its Competitors

Bluebird Bio Inc Share Performance -42.81% This Year

Bluebird Bio Inc Profile Bluebird Bio Inc's business model focuses on developing gene therapies for severe genetic diseases and cancer. They collaborate with academic and industry partners to leverage their gene editing and cell-based technologies for discovering potential treatments and advancing these therapies through clinical trials. More about Bluebird Bio Inc 's Market Share

Unity Biotechnology Inc Share Performance -31.68% Over The Past 5 Days

Unity Biotechnology Inc Profile Unity Biotechnology Inc. is a biotechnology company that focuses on developing therapies to treat age-related diseases. Their business model revolves around identifying and targeting specific senescent cells to address age-related conditions like osteoarthritis, kidney disease, and ophthalmic diseases. By leveraging their expertise in cellular senescence, Unity Biotechnology aims to develop innovative treatments that have the potential to extend healthy human lifespan. More about Unity Biotechnology Inc 's Market Share

2seventy Bio Inc Share Performance +0.81% 30 Days

2seventy Bio Inc Profile 2seventy Bio Inc operates on a business model centered around the development and commercialization of innovative genetic therapies. They strive to harness the power of biotechnology to address complex diseases and improve patient outcomes. By advancing their proprietary gene delivery technologies and collaborating with industry partners, they aim to create scalable treatments that revolutionize the field of genetic medicine. More about 2seventy Bio Inc 's Market Share

Tempest Therapeutics Inc Share Performance -31.37% This Quarter

Tempest Therapeutics Inc Profile Tempest Therapeutics Inc is a biotechnology company focused on developing small molecule therapeutics to treat cancer and other diseases. Their business model revolves around identifying novel targets within the immune system and designing drugs that modulate these targets to enhance the body's immune response against cancer cells. Through strategic collaborations and partnerships, they aim to accelerate the development and commercialization of their product candidates. More about Tempest Therapeutics Inc 's Market Share

Alaunos Therapeutics Inc Share Performance -50.61% This Year

Alaunos Therapeutics Inc Profile Alaunos Therapeutics Inc is a biotechnology company that operates on a research and development business model. Their focus is on discovering and developing innovative therapies for various diseases and medical conditions. Through their scientific expertise and collaborations, they aim to bring novel treatments to market to improve patient outcomes. More about Alaunos Therapeutics Inc 's Market Share

Sources: Boundless Bio Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, August 31, 2026 3:00 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Boundless Bio Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.